Page last updated: 2024-10-15

zinc(ii) phthalocyanine trisulfonic acid

Description

zinc(II) phthalocyanine trisulfonic acid: agent for photodynamic therapy [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID138756711
MeSH IDM0174272

Synonyms (5)

Synonym
znpcs
zinc(ii) phthalocyanine trisulfonic acid
61569-02-6
zinc trisulfonatophthalocyanine
zincate(3-), (29h,31h-phthalocyaninetrisulfonato(5-)-n29,n30,n31,n32)-, trihydrogen

Compound-Compound Interactions

ExcerptReference
"To explore the anti-lymphoma efficacy of ZnPcS(2)P(2)-mediated photodynamic therapy(PDT) combined with mGM-CSF and mB7."( [Anti-lymphoma effects of ZnPcS2P2-mediated photodynamic therapy combined with mGM-CSF and mB7.1 gene-modified vaccine].
Chen, YZ; Huang, HF; Li, NN; Wu, Y, 2006
)
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (42)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (2.38)18.2507
2000's6 (14.29)29.6817
2010's18 (42.86)24.3611
2020's17 (40.48)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other42 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]